Spruce Biosciences (SPRB)

• Market cap: $85.6M
• 1 day: 8.53%
• 5 days: -10.13%
• 1 month: -15.93%
• 3 months: -54.37%
• 6 months: 716.22%
• Year to date: -11.81%
• 1 year: 188.25%
• 5 years: -94.9%
• 10 years: -93.73%
• Sector: Healthcare
• Industry: Biotechnology

About: Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.

Employees: 20